You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: March 28, 2024

Fosfomycin tromethamine - Generic Drug Details


✉ Email this page to a colleague

« Back to Dashboard


What are the generic sources for fosfomycin tromethamine and what is the scope of patent protection?

Fosfomycin tromethamine is the generic ingredient in two branded drugs marketed by Alkem Labs Ltd, Cipla, Xiromed, and Zambon Spa, and is included in four NDAs. Additional information is available in the individual branded drug profile pages.

There are two drug master file entries for fosfomycin tromethamine. Six suppliers are listed for this compound.

Summary for fosfomycin tromethamine
Drug Prices for fosfomycin tromethamine

See drug prices for fosfomycin tromethamine

Recent Clinical Trials for fosfomycin tromethamine

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Benova (Tianjin) Innovative medicine Research Co., Ltd.Phase 3
SaltroPhase 3
MJM BontenPhase 3

See all fosfomycin tromethamine clinical trials

Medical Subject Heading (MeSH) Categories for fosfomycin tromethamine

US Patents and Regulatory Information for fosfomycin tromethamine

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Xiromed FOSFOMYCIN TROMETHAMINE fosfomycin tromethamine FOR SOLUTION;ORAL 212548-001 Oct 6, 2020 AA RX No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Cipla FOSFOMYCIN TROMETHAMINE fosfomycin tromethamine FOR SOLUTION;ORAL 211881-001 Jan 26, 2022 AA RX No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Zambon Spa MONUROL fosfomycin tromethamine FOR SOLUTION;ORAL 050717-001 Dec 19, 1996 AA RX Yes Yes ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Alkem Labs Ltd FOSFOMYCIN TROMETHAMINE fosfomycin tromethamine FOR SOLUTION;ORAL 214554-001 Oct 21, 2021 AA RX No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.